Bard PowerPort Lawsuits 2026: Catheter Fracture and Migration — Do You Qualify?
Patients implanted with a Bard PowerPort who suffered a catheter fracture, catheter migration, a blood clot, or an infection that required additional surgery may have a legal claim. Federal lawsuits over the implantable port are consolidated in MDL No. 3081 in the U.S. District Court for the District of Arizona, where plaintiffs allege the device's catheter is prone to breaking apart and traveling through the bloodstream.
Key facts
- A Bard PowerPort is a totally implantable vascular access device — a small port placed under the skin with a catheter threaded into a large vein, used for chemotherapy and long-term IV therapy.
- Federal PowerPort lawsuits are centralized as MDL No. 3081 in the U.S. District Court for the District of Arizona.
- Plaintiffs allege the catheter can fracture (break apart) and migrate (move) within the body, and can also cause blood clots, infections, and cardiac injury.
- Qualification generally requires an actual Bard PowerPort device — not a competitor's port — plus a documented complication such as fracture, migration, thrombosis, or infection.
- Compensation varies widely by case, and most settlements in product-liability litigation are confidential.
What a Bard PowerPort is
A PowerPort is a totally implantable vascular access device, commonly called a port-a-cath. A surgeon places a small reservoir under the skin — usually in the upper chest — and threads a thin catheter into a large central vein. Nurses and doctors then access the port with a special needle to deliver chemotherapy, antibiotics, or fluids and to draw blood, sparing the patient repeated needle sticks over months or years of treatment. Bard (now part of BD) markets several PowerPort models, and the lawsuits concern the catheter component of the device.
The alleged defect: fracture and migration
Catheter fracture means the thin tube breaks apart inside the body; migration means a piece — or the catheter itself — moves from its intended position. Plaintiffs allege that the PowerPort catheter, made with a polyurethane material containing barium sulfate, can degrade over time and inside the body, making it susceptible to fracturing and to fragments traveling through the venous system toward the heart and lungs. The lawsuits further allege that fractured or migrated fragments can cause pulmonary embolism, cardiac perforation, dangerous blood clots (thrombosis), and deep infections requiring emergency intervention. Whether the design was unreasonably dangerous is the central question the litigation must answer.
Symptoms that can signal a fracture or migration
Because a port sits inside the body, a fracture is not always obvious. Warning signs reported in cases include sudden chest or shoulder pain, an irregular heartbeat, difficulty drawing blood from the port or infusing through it, swelling or pain along the catheter path, unexplained shortness of breath, and signs of infection such as fever and redness around the port site. Any of these symptoms in a patient with an implanted port warrants prompt medical attention — and imaging, such as a chest X-ray or CT scan, is how physicians typically confirm whether the catheter has fractured or moved.
The qualification checklist lawyers use
Firms evaluating PowerPort cases generally require three things. First, proof the implanted device was a Bard PowerPort — operative reports, device labels, or implant cards identifying the Bard brand, because ports made by other manufacturers are not part of this litigation. Second, a documented complication: imaging showing fracture or migration, a diagnosis of thrombosis or embolism linked to the device, a device-related infection, or a revision or removal surgery. Third, a filing deadline that has not expired. A port that simply worked as intended, or a port made by another company, does not form the basis of a claim.
MDL 3081: where the litigation stands
PowerPort cases filed in federal court are consolidated in MDL No. 3081 before the U.S. District Court for the District of Arizona. As with all multidistrict litigation, the MDL handles shared pretrial work — document discovery, expert testimony, and bellwether trial selection — while each plaintiff retains an individual case and an individual outcome. The litigation is now in an active phase, with early trial activity expected to shape the direction of settlement discussions. Our Bard PowerPort October 2026 update tracks the latest developments. For plain-language explanations of how mass-tort cases like this one work, see the Problem Solved channel: https://www.youtube.com/@problemsolved-x3m.
The evidence that strengthens a claim
The strongest files share a common feature: a clear paper trail. Gather your operative report from the implantation surgery, the device identification sticker or implant card, all imaging studies (X-ray, CT, ultrasound) with radiology reports, hospital records from any revision or removal procedure, and records of related treatment such as blood-thinner prescriptions or infection management. Photographs of the port site and a written timeline of symptoms also help. If your records are scattered across hospitals, request them now — medical providers can take weeks to respond.
Deadlines: the statute of limitations
A statute of limitations is the legal deadline for filing suit, and it differs by state — often one to three years for injury claims. Many states apply a discovery rule, so the clock may run from when you discovered (or reasonably should have discovered) the fracture or its link to the device, rather than the implantation date. But the analysis is technical and varies by jurisdiction, and a missed deadline ends the claim regardless of its merit. If imaging has shown a fractured or migrated PowerPort catheter, do not delay a legal evaluation.
What to do if you think you have a claim
Confirm the brand of your device first — check your operative report or implant card for "Bard PowerPort." Then assemble the complication records described above. Consult a firm active in MDL 3081; most take these cases on contingency, with no upfront fee. Also useful: our IVC filter lawsuit guide and the hernia mesh qualification guide, which cover similar medical-device litigation.
This article provides general information about the Bard PowerPort litigation. It is not legal or medical advice. Consult a qualified attorney in your state about your situation.
Who Benefits From This — and Who Does Not
Patients with a Bard device and a documented complication. If your implanted port was a Bard PowerPort — confirmed by your operative report, device label, or implant card — and imaging showed a catheter fracture or migration, or you suffered a device-linked thrombosis, embolism, infection, or revision or removal surgery, you are the core reader of this guide: the first step is to confirm the brand, then assemble the complication records.
Patients whose device is still implanted. Removal or revision surgery is not required to file: a documented fracture, migration, clot, or infection may support a claim even if the device remains implanted, and an attorney can assess your records.
Who does not benefit. A port that simply worked as intended does not form the basis of a claim, and neither does a port made by another manufacturer — only Bard-manufactured devices are part of this litigation. Without a documented complication, or once the filing deadline in your state has expired, this guide offers no path. A related implanted-device case is explained in our guide to Medtronic Infuse lawsuits.
Frequently asked questions
What is the Bard PowerPort lawsuit about?
Plaintiffs allege that the Bard PowerPort's catheter can fracture and migrate inside the body — and can cause blood clots, infections, and cardiac injuries — due to a defective design. Federal cases are consolidated in MDL No. 3081 in the District of Arizona.
How do I know if my port was a Bard PowerPort?
Check your operative report, device implant card, or the device sticker in your hospital records for the Bard PowerPort brand name. Only Bard-manufactured devices are part of this litigation.
What complications can qualify for a claim?
Typically a documented catheter fracture or migration confirmed by imaging, or a device-related thrombosis, embolism, infection, or revision/removal surgery. Each case is evaluated on its own records.
Is there a PowerPort settlement?
No confirmed global settlement has been announced. The MDL remains active, and most settlements in mass-tort litigation are confidential — treat online payout figures as unverified.
Do I need to have the device removed to file?
Not necessarily. Removal or revision surgery strengthens a file, but documented fracture, migration, clots, or infection may support a claim even if the device remains implanted. An attorney can assess your records.
Who benefits from this guide, and how do I start?
The guide benefits patients whose implanted port was a Bard PowerPort and who suffered a documented complication — imaging showing fracture or migration, a device-linked thrombosis or embolism, a device-related infection, or revision or removal surgery. Start here: confirm the brand from your operative report or implant card, gather the operative report, device sticker or implant card, all imaging studies with radiology reports, and records of any revision procedure — then get a legal evaluation promptly, since the filing deadline in your state may run from when you discovered the fracture or its link to the device.